Trial Profile
Clinical efficacy and safety of Tenofovir disoproxil in chinese chronic hepatitis B patients with genotypic resistance
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Sep 2017
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 08 Sep 2017 New trial record